Original Research
Published on 02 Jun 2022
Zoledronic Acid Targeting of the Mevalonate Pathway Causes Reduced Cell Recruitment and Attenuates Pulmonary Fibrosis
in Respiratory Pharmacology
- 4,598 views
- 7 citations
Original Research
Published on 02 Jun 2022
in Respiratory Pharmacology
Original Research
Published on 02 Jun 2022
in Respiratory Pharmacology
Original Research
Published on 01 Jun 2022
in Respiratory Pharmacology
Opinion
Published on 31 May 2022
in Respiratory Pharmacology
Original Research
Published on 31 May 2022
in Respiratory Pharmacology
Original Research
Published on 31 May 2022
in Respiratory Pharmacology
Original Research
Published on 26 May 2022
in Respiratory Pharmacology
Original Research
Published on 20 May 2022
in Respiratory Pharmacology
Original Research
Published on 20 May 2022
in Respiratory Pharmacology
Original Research
Published on 20 May 2022
in Respiratory Pharmacology
Editorial
Published on 19 May 2022
in Respiratory Pharmacology
Original Research
Published on 19 May 2022
in Respiratory Pharmacology
Review
Published on 17 May 2022
in Respiratory Pharmacology
Original Research
Published on 12 May 2022
in Respiratory Pharmacology
Review
Published on 11 May 2022
in Respiratory Pharmacology
Original Research
Published on 11 May 2022
in Respiratory Pharmacology